Replies to post #339499 on NorthWest Biotherapeutics Inc (NWBO)

[GoodGuyBill]

I agree. But I sometimes wonder if NWBO will be sold on the cheap ($5 or so) and the new company will then release a shit load of PRs regarding UK, Germany, Europe, Canada RA endpoint change acceptance, FDA endpoint changes, Sawston buildout completion, Flaskworks technology implementation, DCVAX-L P3 TLD, etc. The stock will skyrocket...after retail shareholders are out of the picture.

This, perhaps, would explain why NWBO seldom announce new developments that shareholders find via their own dd. Why else wouldn't LP announce any of the above non-TLD new worthy events?! Please don't tell me she wants to prevent all of shorts from taking advantage of shareholders.

I agree. However, I think the company will be sold before it can realize that price, as that kind of market cap is years down the line. But who knows?